Benevolent AI (XAMS:BAI) Debt-to-EBITDA : -0.09 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Benevolent AI's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1.07 Mil. Benevolent AI's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €4.44 Mil. Benevolent AI's annualized EBITDA for the quarter that ended in Dec. 2023 was €-63.67 Mil. Benevolent AI's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.09.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Benevolent AI's Debt-to-EBITDA or its related term are showing as below:

XAMS:BAI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.21 Med: -0.07 Max: -0.04
Current: -0.07

During the past 6 years, the highest Debt-to-EBITDA Ratio of Benevolent AI was -0.04. The lowest was -0.21. And the median was -0.07.

XAMS:BAI's Debt-to-EBITDA is ranked worse than
100% of 274 companies
in the Biotechnology industry
Industry Median: 1.31 vs XAMS:BAI: -0.07

Benevolent AI Debt-to-EBITDA Historical Data

The historical data trend for Benevolent AI's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Debt-to-EBITDA Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.21

-0.17

-0.07

-0.04

-0.07

Benevolent AI Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial				-0.06	-0.03	-0.13	-0.08	-0.09

Competitive Comparison of Benevolent AI's Debt-to-EBITDA

For the Biotechnology subindustry, Benevolent AI's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Debt-to-EBITDA falls into.

Benevolent AI Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Benevolent AI's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.074	+	4.438)	/	-80.608
	=	-0.07

Benevolent AI's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.074	+	4.438)	/	-63.67
	=	-0.09

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Benevolent AI (XAMS:BAI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Benevolent AI Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (XAMS:BAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

BAIVF:USA 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI (XAMS:BAI) Headlines

No Headlines